News from collplant A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Mar 14, 2023, 07:00 ET COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2022 FULL YEAR FINANCIAL RESULTS AND CONFERENCE CALL INFORMATION

CollPlant Biotechnologies (Nasdaq: CLGN), a regenerative and aesthetics medicine company developing innovative technologies and products based on its ...

Jan 24, 2023, 07:00 ET CollPlant Issues Letter to Shareholders

CollPlant (Nasdaq: CLGN), a regenerative and aesthetics medicine company developing innovative technologies and products for tissue regeneration and...

Jan 04, 2023, 07:00 ET CollPlant Announces Successful Pre-Clinical Results in 3D Bioprinted Regenerative Breast Implants Porcine Study and Full Achievement of Objectives

Study demonstrated progressive stages of tissue regeneration as highlighted by the formation of maturing connective tissue and neovascular networks...

Jan 03, 2023, 07:00 ET CollPlant Enriches Portfolio of rhCollagen-Based Bioinks with Launch of Collink.3DTM 50L in Powder Form

CollPlant (Nasdaq: CLGN), a regenerative and aesthetics medicine company developing innovative human collagen-based technologies and products for...

Dec 01, 2022, 07:00 ET CollPlant Biotechnologies Provides Business Updates and Third Quarter 2022 Financial Results

Partnership with AbbVie to co-develop rhCollagen-based dermal and soft tissue fillers continues to advance according to plan Co-developing 3D...

Nov 15, 2022, 07:00 ET CollPlant, Tel Aviv University and Sheba Medical Center Join Forces to Co-Develop rhCollagen-Based 3D Bioprinted Human Intestine Model for Drug Discovery and Personalized Treatment of Ulcerative Colitis

CollPlant (NASDAQ: CLGN), a regenerative and aesthetic medicine company developing innovative human collagen-based technologies and products,...

Nov 07, 2022, 07:00 ET CollPlant Expands rhCollagen-Based Bioink Platform with Launch of Collink.3D™ 90

CollPlant (Nasdaq: CLGN), a regenerative and aesthetics medicine company developing innovative human collagen-based technologies and products for...

Nov 03, 2022, 07:00 ET CollPlant to Present at Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum on November 17

CollPlant Biotechnologies (NASDAQ: CLGN), a regenerative and aesthetics medicine company developing innovative human-collagen based technologies and...

Oct 03, 2022, 07:00 ET CollPlant to present at the Dawson James Small Cap Growth Conference on October 12

CollPlant Biotechnologies (Nasdaq: CLGN), a regenerative and aesthetics medicine company developing innovative technologies and products for tissue...

Sep 19, 2022, 07:00 ET CollPlant to Present at the International Conference on Biofabrication 2022 in Tuscany, Italy

CollPlant (NASDAQ: CLGN), a regenerative and aesthetics medicine company developing innovative human collagen-based technologies and products for...

Sep 06, 2022, 07:00 ET CollPlant Biotechnologies to Participate in September Investor Conferences

CollPlant Biotechnologies (Nasdaq: CLGN), a regenerative and aesthetic medicine company developing innovative human collagen-based technologies and...

Aug 25, 2022, 07:00 ET CollPlant Biotechnologies Provides Business Updates and Second Quarter 2022 Financial Results

CollPlant Biotechnologies (NASDAQ: CLGN), a regenerative and aesthetic medicine company developing innovative human collagen-based technologies and...

Jul 05, 2022, 07:00 ET CollPlant to Present and Exhibit at TERMIS Annual Conference in Toronto, Canada

CollPlant (NASDAQ: CLGN), a regenerative and aesthetics medicine company developing innovative technologies and products for tissue regeneration and...

Jun 29, 2022, 08:45 ET CollPlant Advances its 3D Bioprinted Regenerative Breast Implants into Porcine Study

CollPlant (Nasdaq: CLGN), a regenerative and aesthetics medicine company developing innovative technologies and products for tissue regeneration and...

May 26, 2022, 07:00 ET CollPlant Biotechnologies Provides Business Updates and First Quarter 2022 Financial Results

CollPlant Biotechnologies (NASDAQ: CLGN), a regenerative and aesthetic medicine company developing innovative technologies and products for tissue...

Apr 25, 2022, 07:00 ET CollPlant CEO Yehiel Tal to Moderate ISBF's virtual event on Biofabrication of Microphysiological Systems for Drug Discovery and Screening

CollPlant (Nasdaq: CLGN), a regenerative and aesthetics medicine company developing innovative technologies and products for tissue regeneration and...

Apr 13, 2022, 07:00 ET CollPlant To Present at the Aesthetics Innovation Summit 2022

CollPlant (NASDAQ: CLGN), a regenerative and aesthetics medicine company developing innovative technologies and products for tissue regeneration and...

Mar 24, 2022, 07:00 ET CollPlant Biotechnologies Provides Business Updates and Fiscal Year 2021 Financial Results

CollPlant Biotechnologies (NASDAQ: CLGN), a regenerative and aesthetic medicine company developing innovative technologies and products for tissue...

Jan 05, 2022, 07:00 ET CollPlant Issues Letter to Shareholders

CollPlant Biotechnologies (Nasdaq: CLGN), a regenerative and aesthetic medicine company developing innovative technologies and products for tissue...

Dec 02, 2021, 07:00 ET CollPlant Announces Publication Highlighting its rhCollagen-based Photocurable Dermal Filler in the Plastic and Reconstructive Surgery Journal

CollPlant Biotechnologies (Nasdaq: CLGN), a regenerative and aesthetic medicine company developing innovative technologies and products for tissue...

Nov 18, 2021, 07:00 ET CollPlant Biotechnologies Provides Business Updates and Third Quarter 2021 Financial Results

CollPlant Biotechnologies (NASDAQ: CLGN), a regenerative and aesthetic medicine company developing innovative technologies and products for tissue...

Nov 15, 2021, 07:00 ET CollPlant Announces Commercial Launch of BioInk Platform with Collink.3D™ for Use in 3D Bioprinting of Human Tissues, Scaffolds and Organs

CollPlant Biotechnologies (Nasdaq: CLGN), a regenerative and aesthetics medicine company developing innovative technologies and products for tissue...

Oct 14, 2021, 07:00 ET CollPlant to Present at Dawson James Small Cap Growth Conference on October 21st

REHOVOT, Israel, Oct. 14, 2021 /PRNewswire/ - CollPlant Biotechnologies (Nasdaq: CLGN), a regenerative and aesthetics medicine company developing...

Oct 11, 2021, 07:00 ET CollPlant's rhCollagen BioInk Used by Technion Researchers to Develop 3D Bioprinted Vascularized Tissue Constructs

CollPlant Biotechnologies (Nasdaq: CLGN), a regenerative and aesthetics medicine company developing innovative technologies and products for tissue...

Sep 30, 2021, 07:00 ET CollPlant to Present at Fall Harvest - Best Ideas from the Buy-Side on October 5, 2021

CollPlant Biotechnologies (NASDAQ: CLGN), a regenerative and aesthetics medicine company developing innovative technologies and products for tissue...